
India Restricts Stem Cell Therapy for Critical Limb Ischemia
The story in brief
India's ministry of health and family welfare has imposed strict regulations on stem cell therapy for critical limb ischemia and chronic wounds, allowing use only in rigorously conducted trials. The guidelines highlight risks of bias, limited evidence, and the need for oversight, as current treatments remain limited. The ministry emphasized that stem cell therapy is not recommended for routine clinical use.